The effectiveness of a PRF-DRG treatment on radicular neuropathic pain - Effectiveness PRF-DRG

Medisch Spectrum Twente0 个研究点目标入组 46 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•-Subjects should have lumbar of sacral radicular neuropathic pain in dermatome L4, L5 or S1 where the pain is limited for 1 dermatome for at least 3 months. The subjects should have a pain reduction of minimum 50% with a VAS score from 0 to 10 after a diagnostic block.
•- Subject is between 18 and 75 year
•- Subject has a pain score of 4 or above (visual analog scale, VAS: 0-10 from no pain to worst pain).
•- Subject has no new pain medication 2 weeks before the treatment.
•- Informed consent.

•- Subject has sensory deficits at the QST site resulting from such medical conditions such as diabetes, alcoholic neuropathy, AIDS neuropathy, severe thyroid, liver or kidney diseases.
•- Former PRF and RF treatment of the same nerve root.
•- Subject has scar tissue, infection, or acute injury at the QST site.
•- Language barriers and other problems impairing the reliable completion of questionnaires.
•- Subject is pregnant.
•- Subject has a pacemaker.
•- Subject has a major psychiatric disease or dementia.
•- History of back surgery.
•- Other chronic pain (such as fibromyalgia).
•- Anticoagulation in form of vitamin K antagonists which should not be stopped.
•- Skin diseases (such as herpes zoster, burns etc.)
•- Allergy for contrast or lidocaine

发起方